The issue received bids for 66.13 crore shares as against 1.25 crore shares on offer.
The initial public offer (IPO) of Medplus Health Services received bids for 66,13,67,268 shares as against 1,25,75,154 shares on offer. The issue was subscribed 52.59 times.
The qualified institutional buyers category was subscribed 111.89 times. The non institutional investors category was subscribed 85.33 times. The retail investors category was subscribed 5.23 times.
The issue opened for bidding on 13 December 2021 and it closed on 15 December 2021. The price band of the IPO was fixed at Rs 780-796.
Ahead of the IPO, Medplus Health Services on 9 December 2021, finalized allocation of 52,51,111 equity shares to anchor investors at Rs 796 each, aggregating to Rs 417.98 crore.
The IPO comprised fresh issue of equity shares worth up to Rs 600 crore and an offer for sale of Rs 798.30 crore by existing shareholders.
The objectives of the fresh issue are funding working capital requirements of material subsidiary, Optival, for Rs 467.17 crore of and remaining amount to be used for general corporate purposes.
Incorporated in 2006, MedplusHealth Services is the second largest pharmacy retailer in India, in terms of revenue from operations for the financial year 2021 and number of stores as of 31 March 2021. The company offers a wide range of products, including pharmaceutical and wellness products, including medicines, vitamins, medical devices, and test kits, and fast-moving consumer goods, such as home and personal care products, including toiletries, baby care products, soaps and detergents, and sanitizers.
The company is the first pharmacy retailer in India to offer an omni-channel platform. Through this omni-channel model, company seeks to deepen and extend its customer reach for each of its stores, enhance "convenience" as a core customer value proposition and retain customers. The company's revenue from online sales channel has steadily increased. For the financial year 2021, 2020 and the six months ended 30 September 2021, online sales accounted for 8.98%, 6.99% and 8.44% of total revenue from operations, respectively.
The company reported a net profit of Rs 66.91 crore on net sales of Rs 1,879.92 crore in six month ended September 2021.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
